This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
New Frontier’s Psychiatric & TMS is now the first mental health clinic in Milwaukee to offer BrainsWay Deep TMS. Clinical Director, Dr. Hong Yin, is featured by CBS Milwaukee, discussing the new TMS offering and potential benefits to mental health patients in the Milwaukee community.